Schedule 13D ownership disclosure

Petros Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 71678J100

Event date: 2020-12-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,648
Percent of class
0.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-20-001140
Form type
SC 13D
Filer
Petros Pharmaceuticals, Inc.
CIK
CIK 1815903
Filed
Dec 11, 2020
Reporting period
Dec 01, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub